Welcome To ChemAnalyst
Polysorbate market in India rose sharply on export offers, higher logistics costs, downstream buying, tightening availability. Shanghai-JNPT freight gains lifted landed parity and kept imported volumes competitive despite thin domestic output. ester plants conducted maintenance, trimming spot allocations to Asia and extending lead times, while Chinese suppliers prioritized higher-margin ethoxylation products. Buyers showed limited resistance to higher offers as polysorbate remains a small share of finished-dose costs; regulatory restocking boosted procurement activity. Demand strength was clearest in pharmaceutical-grade applications, with vaccine formulators and manufacturers ramping for immunisation drives. Food and personal-care segments supported demand, with snacks rising and personal-care buyers front-loading ahead of mid-year festivals. The market repriced, with retail ex-Mumbai moving higher. Supply pressures persisted: domestic supply represented a substantial share of needs, imports bearing the balance, and freight volatility driving costs higher. Near-term upside risk persists into May, with potential gains supported by raw-material costs and pharma purchasing, though easing feedstock costs or freight rates could moderate momentum.
Polysorbate prices in India climbed sharply in April as a convergence of firm export offers, elevated logistics costs and sustained downstream buying tightened availability across the market. Early-to-late April saw the Shanghai–JNPT freight index surge, lifting landed import parity and keeping imported volumes competitive despite thin domestic output. Tightness in ethoxylation-linked supply chains, driven by Chinese producers prioritizing higher-margin derivatives has constrained availability of key surfactant intermediates. This imbalance, combined with India’s heavy reliance on Chinese imports for organic chemicals and pharma inputs, continues to exert upward pressure and volatility on polysorbate pricing in the domestic market. Meanwhile, buyers displayed limited resistance to higher offers, polysorbate represents a small share of finished-dose cost for many formulators, and regulatory and festival-driven restocking amplified procurement activity.
Polysorbate demand strength was most evident in pharmaceutical-grade applications, where bulk purchases from vaccine formulators and three contract manufacturers ramping for immunisation drives...
We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.
